Patent · US Active

Therapeutic compounds and compositions

US8889667B2 · kind B2 · utility

28Cited by
39References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2011
Grant dateNov 18, 2014
Priority date
Expiry dateDec 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.